Indian pharma sues Kenya agent over fake drugs

Anti-retroviral (ARV) drugs. Cipla says it fears its brand could be damaged should any consumer be affected by the counterfeit ARV drugs. PHOTO | FILE

An Indian pharmaceutical company has sued a Kenyan agent for allegedly importing counterfeit drugs after terminating a contract that the two companies had.

Cipla Limited claims in court documents that its former Kenyan agent, Lords Healthcare, has been importing counterfeit drugs using the Indian firm’s drug registration certificates.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.